GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/15247/37196_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22725/151909_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
HEPACAM | Hepatic and glial cell adhesion molecule | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25486/59721_A_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
HOMER1 | Homer homolog 1 (Drosophila) | | | ![](/images/36522/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4437/11626_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
HS6ST3 | Heparan sulfate 6-O-sulfotransferase 3 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51513/127124_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44535/99160_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
JAKMIP2 | Janus kinase and microtubule interacting protein 2 | Plasma proteins Predicted membrane proteins
| ![](/images/46929/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/46929/108393_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42434/134323_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNIP3 | Kv channel interacting protein 3, calsenilin | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/6907/ihc_cell_selected_60x60.jpg) | ![](/images/6907/16245_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNIP4 | Kv channel interacting protein 4 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22862/53787_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images/16655/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16655/38509_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted membrane proteins
| | ![](/images/31562/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31562/64061_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/500/873_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
KIAA1467 | KIAA1467 | Predicted membrane proteins
| | ![](/images/10803/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10803/26874_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10896/27468_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
LRRN1 | Leucine rich repeat neuronal 1 | Predicted membrane proteins
| | ![](/images/11071/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11071/29565_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
LRRTM1 | Leucine rich repeat transmembrane neuronal 1 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62660/144003_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | ![](/images/22275/50911_A_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
MAP6 | Microtubule-associated protein 6 | | | ![](/images_static/na_center.gif) | | ![](/images/15442/34823_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7461/20871_B_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
MAPT | Microtubule-associated protein tau | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/151/ihc_cell_selected_60x60.jpg) | ![](/images/151/2562_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
MPP2 | Membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) | | | ![](/images/26486/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26486/54887_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MYO16 | Myosin XVI | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40110/88953_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
NACAD | NAC alpha domain containing | | | ![](/images/20981/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/20981/47918_A_5_4_rna_selected_60x60.jpg) | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/142/2717_A_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | ![](/images/18587/40689_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
NDRG4 | NDRG family member 4 | Predicted membrane proteins
| | ![](/images/15313/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15313/35605_A_4_8_rna_selected_60x60.jpg) | Tissue enhanced |
NEFM | Neurofilament, medium polypeptide | Plasma proteins
| | ![](/images/23138/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10900/54575_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NKG2-E | Uncharacterized protein | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62570/146083_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
NLGN3 | Neuroligin 3 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3183/9372_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NOL4 | Nucleolar protein 4 | | ![](/images/46740/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/46740/105646_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
NOS1AP | Nitric oxide synthase 1 (neuronal) adaptor protein | Predicted membrane proteins Predicted secreted proteins
| ![](/images/55561/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/55561/152674_A_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
NOVA1 | Neuro-oncological ventral antigen 1 | | ![](/images/4155/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/4155/12243_A_4_6_rna_selected_60x60.jpg) | Tissue enhanced |
NOVA2 | Neuro-oncological ventral antigen 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45607/100192_A_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49799/124577_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | ![](/images/7637/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10346/33773_A_5_4_rna_selected_60x60.jpg) | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/9233/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9233/30543_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
NYAP1 | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 | | ![](/images/22251/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/22251/49669_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
OMG | Oligodendrocyte myelin glycoprotein | Plasma proteins Predicted secreted proteins
| | ![](/images/8206/if_selected_60x60.jpg) | ![](/images/12693/ihc_cell_selected_60x60.jpg) | ![](/images/8206/120253_A_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
PCDHA1 | Protocadherin alpha 1 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images/35969/if_selected_60x60.jpg) | ![](/images/35969/ihc_cell_selected_60x60.jpg) | ![](/images/35969/77561_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
PHACTR1 | Phosphatase and actin regulator 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29755/64357_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PHACTR3 | Phosphatase and actin regulator 3 | | ![](/images/54847/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/54847/127316_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
PIANP | PILR alpha associated neural protein | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10631/151905_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PLCB1 | Phospholipase C, beta 1 (phosphoinositide-specific) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/5334/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57910/134256_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PLXNB3 | Plexin B3 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48046/141335_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins
| | | ![](/images/53419/ihc_cell_selected_60x60.jpg) | ![](/images/54132/129210_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes
| ![](/images/19263/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19263/44273_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
PSRC1 | Proline/serine-rich coiled-coil 1 | | ![](/images/49315/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49315/119379_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PTPRR | Protein tyrosine phosphatase, receptor type, R | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11461/29729_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |